Brokerages Set DocGo Inc. (NASDAQ:DCGO) Price Target at $3.59

Key Points

• DocGo Inc. has received a consensus rating of “Moderate Buy” from six research firms, with an average twelve-month target price of $3.59.
• The company reported a quarterly loss of ($0.11) EPS, missing analysts' expectations, but achieved revenue of $80.42 million for the quarter.
• Institutional investors currently hold 56.44% of DocGo's stock, with notable increases in holdings from firms like P.A.W. Capital Corp and S Squared Technology LLC.

Shares of DocGo Inc. (NASDAQ:DCGO - Get Free Report) have earned an average recommendation of "Hold" from the five analysts that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $3.2375.

Separately, Canaccord Genuity Group boosted their price target on shares of DocGo from $1.45 to $1.60 and gave the company a "hold" rating in a report on Thursday, August 21st.

DocGo Trading Down 6.5%

DCGO stock traded down $0.10 during mid-day trading on Tuesday, reaching $1.45. 901,016 shares of the stock traded hands, compared to its average volume of 284,582. The stock's fifty day moving average is $1.52 and its 200-day moving average is $1.86. The company has a market cap of $141.82 million, a P/E ratio of -7.63 and a beta of 0.97. DocGo has a 52-week low of $1.23 and a 52-week high of $5.68.

DocGo (NASDAQ:DCGO - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.05). DocGo had a negative return on equity of 3.26% and a negative net margin of 4.20%.The company had revenue of $80.42 million during the quarter, compared to analysts' expectations of $77.58 million. DocGo has set its FY 2025 guidance at EPS. Equities research analysts expect that DocGo will post 0.25 earnings per share for the current year.

Institutional Investors Weigh In On DocGo

Several institutional investors have recently bought and sold shares of DCGO. S Squared Technology LLC raised its position in shares of DocGo by 36.8% in the first quarter. S Squared Technology LLC now owns 1,890,976 shares of the company's stock valued at $4,992,000 after purchasing an additional 508,590 shares during the period. Ritholtz Wealth Management acquired a new stake in DocGo during the 1st quarter valued at approximately $316,000. Northern Trust Corp grew its holdings in DocGo by 24.9% during the 4th quarter. Northern Trust Corp now owns 1,606,139 shares of the company's stock worth $6,810,000 after acquiring an additional 320,133 shares during the period. Deutsche Bank AG grew its position in shares of DocGo by 50.6% during the 4th quarter. Deutsche Bank AG now owns 114,323 shares of the company's stock worth $485,000 after buying an additional 38,416 shares during the period. Finally, BNP Paribas Financial Markets acquired a new stake in DocGo in the fourth quarter valued at approximately $322,000. Institutional investors own 56.44% of the company's stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.